Lmao $IMMU +2.7% (announced the issuance of U.S. patent no. 8,562,988 to its majority-owned subsidiary, IBC Pharmaceuticals, for "Novel Strategies for Improved Cancer Vaccines"; the new patent concerns methods and compositions for forming anti-cancer vaccine complexes created with co's proprietary DOCK-AND-LOCK method), NOR +1.5% (announced the appointment of Dale W. Boyles as its new Chief Financial Officer), ERF +0.2% (announced that as a result of strong operational performance, it is increasing its 2013 estimates for annual average and exit production while maintaining its capital spending guidance)